Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 14Polycystic Ovary Syndrome 12Menorrhagia 7Leiomyoma 7Prostatic Neoplasms 2Osteoporosis 2Neoplasm Metastasis 2Hyperandrogenism 2Vaginitis 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Neoplasms 1Infertility, Female 1Hot Flashes 1Estrogen Receptor Positive Breast Cancer 1Estrogen Levels Among Breast Cancer Patients 1Coronary Disease 1Cardiovascular Diseases 1Breast Carcinoma In Situ 1Atrophic Vaginitis 1Anemia 1Anatomic Stage III Breast Cancer AJCC v8 1Abortion, Spontaneous 1

Interventions

Psychiatric Rehabilitation 4Counseling 4Sildenafil Citrate 2Radiotherapy 2High-Intensity Focused Ultrasound Ablation 2Exercise 2methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1bicalutamide 1Vitamin E 1Vitamin D 1Testosterone Propionate 1Testosterone 1Tadalafil 1Sexual Health 1Sex Education 1Robotics 1Restraint, Physical 1Radiosurgery 1Quality of Life 1Prostatectomy 1Pilocarpine 1Phenylephrine 1Phentolamine 1Papaverine 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Menogaril 1Magnetic Resonance Spectroscopy 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sexual Dysfunction, Physiological × Estradiol × Clear all
NCT00698035 2014-06-02

E-String

University of California, San Francisco

Phase 2 Completed
76 enrolled 11 charts
Other

Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡